B. Vastag

发表

Raloxifene prevails in STAR trial, may face easier road to acceptance than previous drugs.

Brian Vastag, B. Vastag, 2006, Journal of the National Cancer Institute.

Many say adult stem cell reports overplayed.

B. Vastag, 2001, JAMA.

New bioethics council offers no recommendations.

B. Vastag, 2002, JAMA.

Breast cancer racial gap examined: no easy answers to explain disparities in survival.

B. Vastag, 2003, JAMA.

Breast Cancer Racial Gap Examined

B. Vastag, 2003 .

Not so fast: research on infectious links to MS questioned.

B. Vastag, 2001, JAMA.

Sewage yields clues to SV40 transmission.

B. Vastag, 2002, JAMA.

Experts urge bioterrorism readiness.

B. Vastag, 2001, JAMA.

Lung screening study to test popular CT scans.

B. Vastag, 2002, JAMA.

Increasing R01 competition concerns researchers.

B. Vastag, 2006, Journal of the National Cancer Institute.

Fear in the Amygdala

B. Vastag, 2002 .

Stem cells step closer to the clinic: paralysis partially reversed in rats with ALS-like disease.

B. Vastag, 2001, JAMA.

Stem Cells Step Closer to the Clinic

B. Vastag, 2001 .

Alarm Sounded on Fake, Tainted Drugs

B. Vastag, 2003 .

Alarm sounded on fake, tainted drugs: some wholesalers are a weak link in a dangerous chain.

B. Vastag, 2003, JAMA.

Cause of Progeria's Premature Aging Found

B. Vastag, 2003 .

Cause of progeria's premature aging found: expected to provide insight into normal aging process.

B. Vastag, 2003, JAMA.

Genome analysis yields mutations linked to hereditary prostate cancer.

B. Vastag, 2002, JAMA.

HSP-90 inhibitors promise to complement cancer therapies

B. Vastag, 2006, Nature Biotechnology.

Ibogaine Therapy: A 'Vast, Uncontrolled Experiment'

B. Vastag, 2005, Science.

Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.

B. Vastag, 2005, Science.

Decade of work shows depression is physical.

B. Vastag, 2002, JAMA.

Study concludes that moderate PSA levels are unrelated to prostate cancer outcomes.

B. Vastag, 2002, JAMA.

Living-Donor Transplants Reexamined

B. Vastag, 2003 .

Living-donor transplants reexamined: experts cite growing concerns about safety of donors.

B. Vastag, 2003, JAMA.

Who's who in biotech

Kendall Powell, C. Sheridan, E. Waltz, 2006, Nature Biotechnology.

Many questions, few answers for testosterone replacement therapy.

B. Vastag, 2003, JAMA.

Does video game violence sow aggression? Studies probe effects of virtual violence on children.

B. Vastag, 2004, JAMA.

Testicular cancer seen as "stalking horse" for other cancers.

B. Vastag, 1999, Journal of the National Cancer Institute.

Cystic Fibrosis Gene Testing a Challenge

B. Vastag, 2003 .

EPA feels heat over flame retardant

B. Vastag, 2008, Nature.

Poised to challenge need for sleep, "wakefulness enhancer" rouses concerns.

B. Vastag, 2004, JAMA.

AAMC President Jordan J. Cohen, MD, Discusses Champion of Medical Education

B. Vastag, 2001 .

Carbon-capture scheme could cause toxic blooms

B. Vastag, 2010 .

US aims to tighten rules on direct-to-consumer drug ads

B. Vastag, 2007, Nature Biotechnology.

Almost serendipity: alcoholism drug reverses drug resistance in vitro.

B. Vastag, 2000, Journal of the National Cancer Institute.

Out of tragedy, identification innovation.

B. Vastag, 2002, JAMA.

Medicare Wrangling Continues

B. Vastag, 2003 .

NIH Institutes launch joint venture to map cancer genome.

B. Vastag, 2006, Journal of the National Cancer Institute.

The beneficial side of prions

B. Vastag, 2009 .

Imaging studies reveal brain changes in children with bipolar disorder.

B. Vastag, 2003, JAMA.

FDA considers tightening regulations for direct-to-consumer advertising.

B. Vastag, 2005, Journal of the National Cancer Institute.

Merits of embryo screening debated.

B. Vastag, 2004, JAMA.

The Siren Song of Disease Eradication

B. Vastag, 2003 .

The siren song of disease eradication: is it out of tune with the times?

B. Vastag, 2003, JAMA.

Ecstasy experts want realistic messages.

B. Vastag, 2001, JAMA.

Prostate disease begs understanding.

B. Vastag, 2001, JAMA.

Breast cancer prevention study aims to overcome drug bias.

B. Vastag, 2001, JAMA.

Insure everyone now, urges IOM.

B. Vastag, 2004, JAMA.

Volunteers see the world and help its people.

B. Vastag, 2002, JAMA.

Addiction poorly understood by clinicians: experts say attitudes, lack of knowledge hinder treatment.

B. Vastag, 2003, Journal of the American Medical Association (JAMA).

Zero-for-Three?

B. Vastag, 2002 .

Helsinki discord? A controversial declaration.

B. Vastag, 2000, JAMA.

In-office opiate treatment "not a panacea": physicians slow to embrace therapeutic option.

B. Vastag, 2003, JAMA.

In-Office Opiate Treatment Not a Panacea

B. Vastag, 2003 .

Hormone replacement therapy falls out of favor with expert committee.

B. Vastag, 2002, JAMA.

Low health literacy called a major problem.

B. Vastag, 2004, JAMA.

Experimental drugs take aim at obesity.

Brian Vastag, B. Vastag, 2003, JAMA.

Congressional Autism Hearings Continue

B. Vastag, 2001 .

Congressional autism hearings continue: no evidence MMR vaccine causes disorder.

B. Vastag, 2001, Journal of the American Medical Association (JAMA).

Pay attention: ritalin acts much like cocaine.

B. Vastag, 2001, Journal of the American Medical Association (JAMA).

do not publish

B. Vastag, 2008 .

Biotechnology: Crossing the barrier

B. Vastag, 2010, Nature.

At polio's end game, strategies differ.

B. Vastag, 2001, JAMA.

Donald M. Berwick, MD, MPP

B. Vastag, 2004 .

Kenneth W. Kizer, MD, MPH: Health Care Quality Evangelist

B. Vastag, 2001 .

Nutrients for prevention: negative trials send researchers back to drawing board.

B. Vastag, 2009, Journal of the National Cancer Institute.

Tea therapy? Out of the cup, into the lab.

B. Vastag, 1998, Journal of the National Cancer Institute.

Federal plan asks for increased drug treatment.

B. Vastag, 2000, Journal of the American Medical Association (JAMA).

Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS.

B. Vastag, 2003, JAMA.

The melting snows of Kilimanjaro

B. Vastag, 2009 .

Knee Replacement Underused, Says Panel

B. Vastag, 2004 .

Shining light on breast tumors.

B. Vastag, 1999, Journal of the National Cancer Institute.

More Children on CNS Drugs

B. Vastag, 2002 .

Warming to a cold war herb: Soviet secret finds its way west

B. Vastag, 2009 .

Old Drugs for a New Bug

B. Vastag, 2003 .

Blame it on the B cells

B. Vastag, 2010 .

Researchers say changes needed in recruitment policies for NIH trials.

B. Vastag, 2003, Journal of the American Medical Association (JAMA).

Gene chips inch toward the clinic.

B. Vastag, 2003, JAMA.

Scientists find connections in the brain between physical and emotional pain.

B. Vastag, 2003, JAMA.

Reviewer leaked Avandia study to drug firm

B. Vastag, 2008, Nature.

Football brain injuries draw increased scrutiny.

B. Vastag, 2002, JAMA.

Detection network gives early cancer tests a push.

B Vastag, B. Vastag, 2000, Journal of the National Cancer Institute.

Preventing prostate cancer: new analyses put finasteride back on the map.

B. Vastag, 2008, Journal of the National Cancer Institute.